SG10201906494PA - Extracellular matrix compositions - Google Patents

Extracellular matrix compositions

Info

Publication number
SG10201906494PA
SG10201906494PA SG10201906494PA SG10201906494PA SG10201906494PA SG 10201906494P A SG10201906494P A SG 10201906494PA SG 10201906494P A SG10201906494P A SG 10201906494PA SG 10201906494P A SG10201906494P A SG 10201906494PA SG 10201906494P A SG10201906494P A SG 10201906494PA
Authority
SG
Singapore
Prior art keywords
extracellular matrix
matrix compositions
soluble
compositions
biocompatible
Prior art date
Application number
SG10201906494PA
Other languages
English (en)
Inventor
Gail Naughton
Frank Ziegler
Mark Baumgartner
Kyle Nickey
Original Assignee
Histogen Inc
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Histogen Inc filed Critical Histogen Inc
Publication of SG10201906494PA publication Critical patent/SG10201906494PA/en

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N5/00—Undifferentiated human, animal or plant cells, e.g. cell lines; Tissues; Cultivation or maintenance thereof; Culture media therefor
    • C12N5/06—Animal cells or tissues; Human cells or tissues
    • C12N5/0602—Vertebrate cells
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61L—METHODS OR APPARATUS FOR STERILISING MATERIALS OR OBJECTS IN GENERAL; DISINFECTION, STERILISATION OR DEODORISATION OF AIR; CHEMICAL ASPECTS OF BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES; MATERIALS FOR BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES
    • A61L27/00—Materials for grafts or prostheses or for coating grafts or prostheses
    • A61L27/36—Materials for grafts or prostheses or for coating grafts or prostheses containing ingredients of undetermined constitution or reaction products thereof, e.g. transplant tissue, natural bone, extracellular matrix
    • A61L27/38—Materials for grafts or prostheses or for coating grafts or prostheses containing ingredients of undetermined constitution or reaction products thereof, e.g. transplant tissue, natural bone, extracellular matrix containing added animal cells
    • A61L27/3895—Materials for grafts or prostheses or for coating grafts or prostheses containing ingredients of undetermined constitution or reaction products thereof, e.g. transplant tissue, natural bone, extracellular matrix containing added animal cells using specific culture conditions, e.g. stimulating differentiation of stem cells, pulsatile flow conditions
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61L—METHODS OR APPARATUS FOR STERILISING MATERIALS OR OBJECTS IN GENERAL; DISINFECTION, STERILISATION OR DEODORISATION OF AIR; CHEMICAL ASPECTS OF BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES; MATERIALS FOR BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES
    • A61L27/00—Materials for grafts or prostheses or for coating grafts or prostheses
    • A61L27/28—Materials for coating prostheses
    • A61L27/34—Macromolecular materials
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61L—METHODS OR APPARATUS FOR STERILISING MATERIALS OR OBJECTS IN GENERAL; DISINFECTION, STERILISATION OR DEODORISATION OF AIR; CHEMICAL ASPECTS OF BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES; MATERIALS FOR BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES
    • A61L29/00—Materials for catheters, medical tubing, cannulae, or endoscopes or for coating catheters
    • A61L29/08—Materials for coatings
    • A61L29/085—Macromolecular materials
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61L—METHODS OR APPARATUS FOR STERILISING MATERIALS OR OBJECTS IN GENERAL; DISINFECTION, STERILISATION OR DEODORISATION OF AIR; CHEMICAL ASPECTS OF BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES; MATERIALS FOR BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES
    • A61L31/00—Materials for other surgical articles, e.g. stents, stent-grafts, shunts, surgical drapes, guide wires, materials for adhesion prevention, occluding devices, surgical gloves, tissue fixation devices
    • A61L31/08—Materials for coatings
    • A61L31/10—Macromolecular materials
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P1/00—Drugs for disorders of the alimentary tract or the digestive system
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P17/00—Drugs for dermatological disorders
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P17/00—Drugs for dermatological disorders
    • A61P17/02—Drugs for dermatological disorders for treating wounds, ulcers, burns, scars, keloids, or the like
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P17/00—Drugs for dermatological disorders
    • A61P17/14—Drugs for dermatological disorders for baldness or alopecia
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P19/00—Drugs for skeletal disorders
    • A61P19/02—Drugs for skeletal disorders for joint disorders, e.g. arthritis, arthrosis
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P27/00—Drugs for disorders of the senses
    • A61P27/02—Ophthalmic agents
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P29/00—Non-central analgesic, antipyretic or antiinflammatory agents, e.g. antirheumatic agents; Non-steroidal antiinflammatory drugs [NSAID]
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P41/00—Drugs used in surgical methods, e.g. surgery adjuvants for preventing adhesion or for vitreum substitution
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P9/00—Drugs for disorders of the cardiovascular system
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P9/00—Drugs for disorders of the cardiovascular system
    • A61P9/10—Drugs for disorders of the cardiovascular system for treating ischaemic or atherosclerotic diseases, e.g. antianginal drugs, coronary vasodilators, drugs for myocardial infarction, retinopathy, cerebrovascula insufficiency, renal arteriosclerosis
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N5/00—Undifferentiated human, animal or plant cells, e.g. cell lines; Tissues; Cultivation or maintenance thereof; Culture media therefor
    • C12N5/0068—General culture methods using substrates
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N5/00—Undifferentiated human, animal or plant cells, e.g. cell lines; Tissues; Cultivation or maintenance thereof; Culture media therefor
    • C12N5/06—Animal cells or tissues; Human cells or tissues
    • C12N5/0602—Vertebrate cells
    • C12N5/0625—Epidermal cells, skin cells; Cells of the oral mucosa
    • C12N5/0627—Hair cells
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N5/00—Undifferentiated human, animal or plant cells, e.g. cell lines; Tissues; Cultivation or maintenance thereof; Culture media therefor
    • C12N5/06—Animal cells or tissues; Human cells or tissues
    • C12N5/0602—Vertebrate cells
    • C12N5/0652—Cells of skeletal and connective tissues; Mesenchyme
    • C12N5/0656—Adult fibroblasts
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N2500/00—Specific components of cell culture medium
    • C12N2500/02—Atmosphere, e.g. low oxygen conditions
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N2500/00—Specific components of cell culture medium
    • C12N2500/90—Serum-free medium, which may still contain naturally-sourced components
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N2501/00—Active agents used in cell culture processes, e.g. differentation
    • C12N2501/10—Growth factors
    • C12N2501/165—Vascular endothelial growth factor [VEGF]
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N2501/00—Active agents used in cell culture processes, e.g. differentation
    • C12N2501/40—Regulators of development
    • C12N2501/415—Wnt; Frizzeled
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N2533/00—Supports or coatings for cell culture, characterised by material
    • C12N2533/90—Substrates of biological origin, e.g. extracellular matrix, decellularised tissue

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Engineering & Computer Science (AREA)
  • Chemical & Material Sciences (AREA)
  • General Health & Medical Sciences (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Organic Chemistry (AREA)
  • Biomedical Technology (AREA)
  • Veterinary Medicine (AREA)
  • Public Health (AREA)
  • Animal Behavior & Ethology (AREA)
  • Zoology (AREA)
  • Wood Science & Technology (AREA)
  • Biotechnology (AREA)
  • Medicinal Chemistry (AREA)
  • Genetics & Genomics (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Cell Biology (AREA)
  • Dermatology (AREA)
  • Epidemiology (AREA)
  • Biochemistry (AREA)
  • General Engineering & Computer Science (AREA)
  • Microbiology (AREA)
  • Heart & Thoracic Surgery (AREA)
  • Transplantation (AREA)
  • Oral & Maxillofacial Surgery (AREA)
  • Rheumatology (AREA)
  • Surgery (AREA)
  • Vascular Medicine (AREA)
  • Botany (AREA)
  • Developmental Biology & Embryology (AREA)
  • Cardiology (AREA)
  • Ophthalmology & Optometry (AREA)
  • Pain & Pain Management (AREA)
  • Immunology (AREA)
  • Urology & Nephrology (AREA)
  • Orthopedic Medicine & Surgery (AREA)
SG10201906494PA 2008-01-30 2009-01-30 Extracellular matrix compositions SG10201906494PA (en)

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
US2485408P 2008-01-30 2008-01-30
US3436108P 2008-03-06 2008-03-06
US5094008P 2008-05-06 2008-05-06

Publications (1)

Publication Number Publication Date
SG10201906494PA true SG10201906494PA (en) 2019-09-27

Family

ID=40913280

Family Applications (2)

Application Number Title Priority Date Filing Date
SG10201906494PA SG10201906494PA (en) 2008-01-30 2009-01-30 Extracellular matrix compositions
SG10201500237TA SG10201500237TA (en) 2008-01-30 2009-01-30 Extracellular matrix compositions

Family Applications After (1)

Application Number Title Priority Date Filing Date
SG10201500237TA SG10201500237TA (en) 2008-01-30 2009-01-30 Extracellular matrix compositions

Country Status (12)

Country Link
US (1) US8257947B2 (fr)
EP (1) EP2262891B1 (fr)
JP (2) JP5647007B2 (fr)
KR (1) KR101650957B1 (fr)
CN (1) CN102066558B (fr)
AP (1) AP3129A (fr)
AU (1) AU2009209022B2 (fr)
BR (2) BR122020017131B1 (fr)
CA (1) CA2714387C (fr)
SG (2) SG10201906494PA (fr)
WO (1) WO2009097559A1 (fr)
ZA (1) ZA201006148B (fr)

Families Citing this family (31)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
WO2008109407A2 (fr) 2007-03-02 2008-09-12 University Of Pittsburgh-Of The Commonwealth System Of Higher Education Gels dérivés de matrice extracellulaire et procédés associés
US9283302B2 (en) 2011-12-16 2016-03-15 Cormatrix Cardiovascular, Inc. Extracellular matrix encasement structures and methods
US8524494B2 (en) * 2008-01-30 2013-09-03 Histogen, Inc. Low oxygen tension and BFGF generates a multipotent stem cell from a fibroblast in vitro
WO2009111087A1 (fr) * 2008-03-07 2009-09-11 Worcester Polytechnic Institute Nouvelle utilisation du facteur de croissance des fibroblastes de base dans la dédifférenciation de cellules de tissus conjonctifs animaux
WO2011006107A1 (fr) * 2009-07-10 2011-01-13 Histogen, Inc. Compositions à base de milieu conditionné et de matrice extracellulaire à partir de cellules cultivées dans des conditions hypoxiques
RU2418066C1 (ru) * 2010-04-26 2011-05-10 Учреждение Российской академии наук Государственный научный центр Российской Федерации-Институт медико-биологических проблем Российской академии наук (ГНЦ РФ-ИМБП РАН) Способ модификации пролиферативной активности и дифференцировочной потенции мультипотентных мезенхимальных стромальных клеток
EP3888714A1 (fr) * 2010-07-31 2021-10-06 Cook Medical Technologies LLC Poche de tissu collagène pour un dispositif médical implantable, et son procédé de fabrication
WO2014058587A1 (fr) * 2012-10-08 2014-04-17 Cormatrix Cardiovascular, Inc. Procédé et système de traitement de tissu biologique
MX366410B (es) * 2013-02-12 2019-07-08 Replicel Life Sciences Inc Composiciones y metodos para tratamiento y reparacion de tendones.
US9820933B2 (en) * 2013-04-19 2017-11-21 Korea University Research And Business Foundation Composition for stimulating hair growth or preventing hair loss which includes extract neural stem cell and method for producing same
US10533191B2 (en) 2014-01-15 2020-01-14 Serucell Corporation Therapeutic serum obtained from co-cultured cells
US10500233B2 (en) 2014-02-12 2019-12-10 Replicel Life Sciences Inc. Compositions and methods for treating bone, joints and cartilage
AU2015231110B2 (en) 2014-03-21 2019-03-07 University Of Pittsburgh - Of The Commonwealth System Of Higher Education Methods for preparation of a terminally sterilized hydrogel derived from extracellular matrix
KR101633585B1 (ko) * 2014-03-31 2016-06-27 아주대학교산학협력단 표면개질된 연골세포 유래 세포외 기질막을 유효성분으로 함유하는 유착방지용 조성물
WO2015152596A1 (fr) * 2014-03-31 2015-10-08 아주대학교산학협력단 Composition destinée à empêcher l'adhésion, contenant en tant que principe actif une membrane de matrice extracellulaire dérivée de chondrocytes à surface modifiée
WO2015164728A1 (fr) * 2014-04-24 2015-10-29 University Of Pittsburgh - Of The Commonwealth System Of Higher Education Fractionnement de la matrice extracellulaire pour moduler l'activité biologique et la réponse de l'hôte
JP6718202B2 (ja) * 2014-06-20 2020-07-08 共栄化学工業株式会社 皮膚外用剤
FR3029116B1 (fr) 2014-12-01 2018-03-30 Advanced Chitosan Solutions Biotech Procede d'obtention d'un gel de cartilage pour la reparation cartilagineuse, comprenant du chitosane et des chondrocytes
FR3032632A1 (fr) * 2015-02-12 2016-08-19 Exel Ind Pistolet de projection d'un fluide, filtre pour un tel pistolet, et procede d'extraction d'un filtre hors d'un tel pistolet
CN104941008A (zh) * 2015-05-19 2015-09-30 烟台正海生物科技股份有限公司 一种引导组织再生膜的制备方法及其应用
CN105769381B (zh) * 2015-05-26 2018-04-17 南通大学 一种用于组织损伤修复的生物补片
JP6587877B2 (ja) * 2015-09-17 2019-10-09 日本メナード化粧品株式会社 表皮幹細胞を分離するためのマーカー及び三次元培養表皮の製造方法
CN106978394B (zh) * 2017-02-23 2020-06-23 北京恒峰铭成生物科技有限公司 一种抗慢性炎症的间充质干细胞的制备方法及其应用
ES2931299T3 (es) 2017-03-02 2022-12-28 Univ Pittsburgh Commonwealth Sys Higher Education Hidrogel de matriz extracelular (ECM) y fracción soluble del mismo para su utilización en el tratamiento del cáncer
US11718829B2 (en) * 2017-07-28 2023-08-08 Breakthrough Tech Llc Methods and compositions for manufacturing extracellular matrix
JP7151203B2 (ja) * 2018-06-19 2022-10-12 東洋インキＳｃホールディングス株式会社 細胞培養培地添加剤、細胞培養培地及び細胞凝集塊の製造方法
CA3107592A1 (fr) * 2018-08-02 2020-02-06 Histogen, Inc. Compositions de milieu conditionne et de matrice extracellulaire, et utilisations de celles-ci
US20210260135A1 (en) * 2018-08-03 2021-08-26 Laboratory Of Cell Applied Technologies, Co Production Method for Culture Supernatant Preparation
CN110607279B (zh) * 2019-10-18 2023-09-19 深圳优圣康医学检验实验室 一种原代肿瘤细胞的3d培养体系及其培养方法和应用
US20210254008A1 (en) * 2020-02-14 2021-08-19 Allergan Sales, Llc Conditioned medium from cells cultured under hypoxic conditions and uses thereof
WO2023167082A1 (fr) * 2022-03-01 2023-09-07 国立大学法人横浜国立大学 Procédé de production de cellules mésenchymateuses de follicule pileux proliférées et son utilisation

Family Cites Families (34)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US4235312A (en) 1978-10-30 1980-11-25 Eaton Corporation Brake actuator assembly
IL74715A0 (en) * 1984-03-27 1985-06-30 Univ New Jersey Med Biodegradable matrix and methods for producing same
US5266480A (en) * 1986-04-18 1993-11-30 Advanced Tissue Sciences, Inc. Three-dimensional skin culture system
US5032508A (en) * 1988-09-08 1991-07-16 Marrow-Tech, Inc. Three-dimensional cell and tissue culture system
US5160490A (en) * 1986-04-18 1992-11-03 Marrow-Tech Incorporated Three-dimensional cell and tissue culture apparatus
US4938763B1 (en) 1988-10-03 1995-07-04 Atrix Lab Inc Biodegradable in-situ forming implants and method of producing the same
US5380746A (en) * 1989-05-05 1995-01-10 Goedecke Aktiengesellschaft Bis-(1H-indol-3-YL)-maleinimide derivatives, processes for the preparation thereof and pharmaceutical compositions containing them
US5091173A (en) * 1989-06-29 1992-02-25 The University Of Dundee Hair growth composition
US5204382A (en) 1992-02-28 1993-04-20 Collagen Corporation Injectable ceramic compositions and methods for their preparation and use
US6733776B1 (en) * 1992-04-02 2004-05-11 Anticancer, Inc. Method for promoting hair growth
US5830708A (en) 1995-06-06 1998-11-03 Advanced Tissue Sciences, Inc. Methods for production of a naturally secreted extracellular matrix
US6284284B1 (en) 1995-06-06 2001-09-04 Advanced Tissue Sciences, Inc. Compositions and methods for production and use of an injectable naturally secreted extracellular matrix
US5833948A (en) 1995-06-15 1998-11-10 Bracco Research S.A. Blood-pool imaging composition comprising micelles containing a lipophilic chelating agent and a non-ionic surfactant
US5888551A (en) * 1995-12-11 1999-03-30 University Of Miami Hair growth stimulating composition
US5866165A (en) * 1997-01-15 1999-02-02 Orquest, Inc. Collagen-polysaccharide matrix for bone and cartilage repair
US6197586B1 (en) * 1997-12-12 2001-03-06 The Regents Of The University Of California Chondrocyte-like cells useful for tissue engineering and methods
US6610540B1 (en) * 1998-11-18 2003-08-26 California Institute Of Technology Low oxygen culturing of central nervous system progenitor cells
ATE305967T1 (de) * 1998-11-19 2005-10-15 Organogenesis Inc Biotechnisch konstruiertes gewebe und verfahren zu dessen produktion und benutzung
US20030007954A1 (en) 1999-04-12 2003-01-09 Gail K. Naughton Methods for using a three-dimensional stromal tissue to promote angiogenesis
US6372494B1 (en) * 1999-05-14 2002-04-16 Advanced Tissue Sciences, Inc. Methods of making conditioned cell culture medium compositions
US6280284B1 (en) 2000-03-17 2001-08-28 Carl Winefordner Toy submarine with counter rotating propellers
JP4813734B2 (ja) * 2000-03-31 2011-11-09 ザ ジェネラル ホスピタル コーポレイション 毛の成長を調節する方法
US20020155440A1 (en) * 2000-12-19 2002-10-24 Ljubimova Julia Y. Using overexpression of laminin alpha 4 subunit as a diagnostic and prognostic indicator of malignant tumors
BR0206855A (pt) 2001-01-30 2006-01-17 Orthogene Inc Composições e suas aplicações para o tratamento de defeitos em cartilagem articular
ITPD20010032A1 (it) * 2001-02-09 2002-08-09 Fidia Advanced Biopolymers Srl Innesti ingegnerizzati per la riparazione di difetti osteocondrali
US20050032208A1 (en) * 2003-06-18 2005-02-10 Oh Steve Kah Weng Materials and methods to produce stem cells
EP1711595B1 (fr) 2003-12-02 2007-11-21 Universiteit Gent Utilisation d'alginate polysulfate pour matrices cellulaires
AU2005300263A1 (en) * 2004-03-09 2006-05-11 Jan-Eric W. Ahlfors Autogenic living scaffolds and living tissue matrices: methods and uses thereof
WO2005104766A2 (fr) * 2004-04-28 2005-11-10 Myocardial Therapeutics, Inc. Injection d'un milieu conditionne derive de la moelle osseuse pour favoriser l'angiogenese
US7828711B2 (en) * 2004-08-16 2010-11-09 Cardiac Pacemakers, Inc. Method and apparatus for modulating cellular growth and regeneration using ventricular assist device
WO2006026617A2 (fr) * 2004-08-30 2006-03-09 Iken Tissue Therapeutics, Inc. Compositions et procedes pour stimuler la croissance capillaire
WO2006026652A2 (fr) * 2004-08-30 2006-03-09 Iken Tissue Therapeutics, Inc. Compositions et procedes faisant intervenir des proteines wnt pour favoriser la reparation de tissus endommages
US20070072294A1 (en) * 2004-09-30 2007-03-29 Doronin Sergey V Use of human stem cells and/or factors they produce to promote adult mammalian cardiac repair through cardiomyocyte cell division
EP1965812A4 (fr) * 2005-11-08 2010-02-24 Georgia Tech Res Inst Materiau bio decellularise derivant de cellules souches d'embryons

Also Published As

Publication number Publication date
ZA201006148B (en) 2011-10-26
AU2009209022B2 (en) 2014-06-12
EP2262891A4 (fr) 2011-04-20
CA2714387A1 (fr) 2009-08-06
EP2262891A1 (fr) 2010-12-22
JP5647007B2 (ja) 2014-12-24
WO2009097559A1 (fr) 2009-08-06
AP2010005380A0 (en) 2010-08-31
JP2011510662A (ja) 2011-04-07
CA2714387C (fr) 2018-06-19
US20100047305A1 (en) 2010-02-25
CN102066558A (zh) 2011-05-18
BRPI0906972A2 (pt) 2015-07-14
EP2262891B1 (fr) 2022-09-21
US8257947B2 (en) 2012-09-04
SG10201500237TA (en) 2015-04-29
BR122020017131B1 (pt) 2023-05-16
CN102066558B (zh) 2017-02-08
JP2014221070A (ja) 2014-11-27
KR101650957B1 (ko) 2016-08-24
AP3129A (en) 2015-02-28
BRPI0906972B1 (pt) 2021-09-08
AU2009209022A1 (en) 2009-08-06
KR20110011599A (ko) 2011-02-08

Similar Documents

Publication Publication Date Title
SG10201906494PA (en) Extracellular matrix compositions
MX2012000455A (es) Composiciones de matriz extra-celular y medio acondicionado a partir de celulas cultivadas bajo condiciones hipoxicas.
CL2007001165A1 (es) 2-(1h-indazol-4-il)-6-(4-metanosulfonil-piperazin-1-ilmetil)-4-morfolin-4-il-tieno[3,2-d]pirimidina; procedimiento de preparacion; composicion farmaceutica; proceso de preparacion de dicha composicion; kit farmaceutico; y uso para tratar enfermedades tales como cancer, desordenes inmunes y enfermedades cardiovasculares.
WO2007080590A3 (fr) Progéniteurs de tissus conjonctifs obtenus à partir de cellules souches embryonnaires humaines à des fins de génie tissulaire
WO2009137624A3 (fr) Cellules formant des colonies hémangioblastiques et cellules hémangioblastiques non transplantables
AU323701S (en) Medical instrument
WO2005007233A3 (fr) Application de stimulation electrique pour le genie tissulaire fonctionnel in vitro et in vivo
EP1797015A4 (fr) Restaurations dentaires haute resistance
GB0415080D0 (en) Methods for preparing tissue equivalent implants and products thereof
MX2010013917A (es) Induccion de floculacion en organismos fotosinteticos.
MY158100A (en) 6,9-disubstituted purine derivatives and their use for treating skin
WO2012002986A3 (fr) Matrice extracellulaire décellularisée et délipidée et procédés d'utilisation
HK1109783A1 (en) Use of cultured three-dimensional tissue for treating congestive heart failure
TW200740416A (en) Corneal onlays and related methods
WO2018186611A3 (fr) Bioencre et son procédé de préparation
WO2004113513A3 (fr) Procedes et compositions pour moduler la croissance et la differentiation des cellules souches
MX2013002406A (es) Diferenciacion de celulas madre embrionarias humanas.
WO2013009595A3 (fr) Matrice extracellulaire (ecm) dérivée du système nerveux central (cns), injectable pour une reconstruction tissulaire
MX365946B (es) Rabdovirus oncolitico.
MY151979A (en) Method for producing mesenchymal stem cells from human pluripotent stem cells, and mesenchymal stem cells produced by same
MX2010007404A (es) Procedimiento para la preparacion de asenapina y productos intermediarios utilizados en dicho procedimiento.
BR112012006283A2 (pt) formulação de adamts13 estabilizada, método para fabricar uma formulação de adamts13 estabilizada, kit, e métodos para tratar ou prevenir uma doença e para tratar ou previnir um enfarte
MX2019015321A (es) Composiciones tridimensionales de tejido y métodos de uso.
ATE531792T1 (de) Dreidimensionale mineralisierte knochenkonstrukte
MX2013002405A (es) Diferenciacion de celulas madre embrionarias humanas.